Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W F Wilson

Showing results (31-40 of 391) with videos related to

Pageof 40
Sort By:
Circulation|September 27, 2017
Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual CarePeter W F Wilson, David Gagnon
Clinical Chemistry|September 17, 2010
How do we find the best biomarkers for cardiovascular disease?Ngoc-Anh Le, Peter W F Wilson
The Journal of Clinical Endocrinology and Metabolism|July 11, 2006
Free fatty acids and atherosclerosis--guilty or innocent?Steven R Smith, Peter W F Wilson
Journal of the American Heart Association|January 28, 2016
Caffeine Consumption and Cardiovascular Risks: Little Cause for ConcernPeter W F Wilson, Heather L Bloom
The American Journal of Geriatric Cardiology|March 2, 2002
Obesity, diabetes, and risk of cardiovascular disease in the elderlyPeter W F Wilson, William B Kannel
Circulation|October 1, 2003
The metabolic syndrome: a practical guide to origins and treatment: Part IIPeter W F Wilson, Scott M Grundy
Statistics in Medicine|November 21, 2017
Risk assessment with newer statistical metricsPeter W F Wilson, Leslee J Shaw
JAMA|January 17, 2014
Formulation of treatment recommendations for statins--replyPaul M Ridker, Peter W F Wilson
JAMA|August 23, 2012
Cardiovascular risk assessment in the 21st centuryJ Michael Gaziano, Peter W F Wilson
Journal of Clinical Lipidology|February 5, 2011
Closing commentPeter W F Wilson, Gloria L Vega
Pageof 40

Showing results (31-40 of 391) with videos related to

Sort By:
Pageof 40
Circulation|September 27, 2017
Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual CarePeter W F Wilson, David Gagnon
Clinical Chemistry|September 17, 2010
How do we find the best biomarkers for cardiovascular disease?Ngoc-Anh Le, Peter W F Wilson
The Journal of Clinical Endocrinology and Metabolism|July 11, 2006
Free fatty acids and atherosclerosis--guilty or innocent?Steven R Smith, Peter W F Wilson
Journal of the American Heart Association|January 28, 2016
Caffeine Consumption and Cardiovascular Risks: Little Cause for ConcernPeter W F Wilson, Heather L Bloom
The American Journal of Geriatric Cardiology|March 2, 2002
Obesity, diabetes, and risk of cardiovascular disease in the elderlyPeter W F Wilson, William B Kannel
Circulation|October 1, 2003
The metabolic syndrome: a practical guide to origins and treatment: Part IIPeter W F Wilson, Scott M Grundy
Statistics in Medicine|November 21, 2017
Risk assessment with newer statistical metricsPeter W F Wilson, Leslee J Shaw
JAMA|January 17, 2014
Formulation of treatment recommendations for statins--replyPaul M Ridker, Peter W F Wilson
JAMA|August 23, 2012
Cardiovascular risk assessment in the 21st centuryJ Michael Gaziano, Peter W F Wilson
Journal of Clinical Lipidology|February 5, 2011
Closing commentPeter W F Wilson, Gloria L Vega
Pageof 40